Evidence map›Paper›PMID 36428810›Full record

ArticleCancers2022

Oocyte Quality Assessment in Breast Cancer: Implications for Fertility Preservation.

Cristina Fabiani, Antonella Guarino, Caterina Meneghini, Emanuele Licata, Gemma Paciotti, Donatella Miriello, Michele Carlo Schiavi, Vincenzo Spina, Roberta Corno, Mariagrazia Gallo and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Cristina FabianiPhysiopathology of Reproduction and Andrology Unit, Sandro Pertini Hospital, 00157 Rome, Italy.ORCID 0000-0001-7525-2550
Antonella GuarinoPhysiopathology of Reproduction and Andrology Unit, Sandro Pertini Hospital, 00157 Rome, Italy.ORCID 0000-0002-7266-8355
Caterina MeneghiniPhysiopathology of Reproduction and Andrology Unit, Sandro Pertini Hospital, 00157 Rome, Italy.
Emanuele LicataPhysiopathology of Reproduction and Andrology Unit, Sandro Pertini Hospital, 00157 Rome, Italy.ORCID 0000-0003-2872-4425
Gemma PaciottiPhysiopathology of Reproduction and Andrology Unit, Sandro Pertini Hospital, 00157 Rome, Italy.ORCID 0000-0003-2202-9720
Donatella MirielloPhysiopathology of Reproduction and Andrology Unit, Sandro Pertini Hospital, 00157 Rome, Italy.
Michele Carlo SchiaviDepartment of Obstetrics and Gynecology, Sandro Pertini Hospital, 00157 Rome, Italy.
Vincenzo SpinaProtection of Maternal and Child Health Unit, 02100 Rieti, Italy.
Roberta CornoPhysiopathology of Reproduction and Andrology Unit, Sandro Pertini Hospital, 00157 Rome, Italy.
Mariagrazia GalloPhysiopathology of Reproduction and Andrology Unit, Sandro Pertini Hospital, 00157 Rome, Italy.
Rocco RagoPhysiopathology of Reproduction and Andrology Unit, Sandro Pertini Hospital, 00157 Rome, Italy.
Ospedale Sandro Pertini · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of this study was to evaluate the effects of breast cancer on the ovarian response and on oocyte quality following controlled ovarian hyperstimulation (COH).

methodsThis retrospective case-control study evaluated the effects of breast cancer on the ovarian response and on the oocyte quality. Oncological patients with breast cancer undergoing controlled ovarian stimulation cycles for fertility preservation, and age- and date-matched controls undergoing COH for in vitro fertilization (IVF) for male or tubal factor infertility were included in the study. Two hundred and ninety-four women were enrolled: 105 affected by breast cancer and 189 healthy women in the control group. Both groups were comparable in terms of age, BMI, and AMH value. Maximal estradiol levels on the triggering day, duration of stimulation, total amount of gonadotropins administered, number of oocytes retrieved, rate of metaphase 2 oocyte production, and numbers of immature and dysmorphic oocytes were analyzed.

resultsConsidering factors influencing the oocyte quality, such as age, BMI, AMH, duration of stimulation, E2 level on the triggering day, total FSH cumulative dose, stage, histotype, BRCA status, and hormone receptors, the univariate and multivariate analyses identified breast cancer as a risk factor for the presence of dysmorphic oocytes.

conclusionsThe diagnosis of breast cancer does not seem to be associated with the impairment of the ovarian reserve, but is linked to a worsening oocyte quality.

Indexed as

breast cancercontrolled ovarian hyperstimulationfertility preservationoocytes quality

Identifiers

PMID36428810
PMCPMC9688559
OpenAlexW4309710758

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.